clinical trial · NCT05542953
[18F]APN-1607 PET in Subjects With AD Compared to HC
Alzheimer's DiseaseMild Cognitive Impairment Due to Alzheimer's DiseaseHealthy Volunteers[18F]APN-1607
brief summary
The overall objective of this study is to compare the overall pattern of \[18F\]APN-1607 uptake in subjects with MCI, subjects with AD dementia, and healthy subjects.
started
Jan 21, 2022
primary completion
Dec 25, 2023
completion
Dec 25, 2023
last updated
Sep 8, 2025
official title
A Phase 3, Multicenter Study of [18F]APN-1607 Positron Emission Tomography in Subjects With Alzheimer's Disease Compared to Healthy Subjects
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol